1 Nieman LK, Biller BMK, Findling JW, et al. The Diagnosis of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 2008;93(5):1526–40.
2 Martin-Grace J, Dineen R, Sherlock M, Thompson CJ. Adrenal insufficiency: Physiology, clinical presentation and diagnostic challenges. Clinica Chimica Acta. 2020;505:78–91.
3 Chan S, Debono M. Review: Replication of cortisol circadian rhythm: new advances in hydrocortisone replacement therapy. Therapeutic Advances in Endocrinology. 2010;1(3):129–38.
4 Charmandari E, Nicolaides NC, Chrousos GP. Adrenal insufficiency. The Lancet. 2014;383(9935):2152–67.
5 Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 2016;101(2):364–89.
6 Manosroi W, Atthakomol P, Buranapin S, Waisayanand N, Phimphilai M, Kosachunhanun N. 30-Minute Delta Cortisol Post-ACTH Stimulation Test and Proposed Cut-Off Levels for Adrenal Insufficiency Diagnosis. J Med Invest. 2020;67(1.2):95–101.
7 Arlt W, Callies F, van Vlijmen JC, et al. Dehydroepiandrosterone Replacement in Women with Adrenal Insufficiency. N Engl J Med. 1999;341(14):1013–20.
8 Gurnell EM, Hunt PJ, Curran SE, et al. Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial. The Journal of Clinical Endocrinology & Metabolism. 2008;93(2):400–9.
9 Schlaghecke R, Kornely E, Santen RTh, Ridderskamp P. The Effect of Long-Term Glucocorticoid Therapy on Pituitary–Adrenal Responses to Exogenous Corticotropin-Releasing Hormone. N Engl J Med. 1992;326(4):226–30.
10 Vollenweider, Waeber. Planifier un sevrage aux glucocorticoïdes: Stratégie diagnostique et thérapeutique. Praxis. 2003;92(40):1675–82.
11 Carter ME, James VH. Effect of alternate-day, single-dose, corticosteroid therapy on pituitary-adrenal function. Annals of the Rheumatic Diseases. 1972;31(5):379–83.
12 Rossini M, Orsolini G, Viapiana O, Adami S, Gatti D. Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros. Endocrine. 2015;49(3):620–7.
13 Sène D, Huong-Boutin DLT, Thiollet M, Barete S, Cacoub P, Piette J-C. Insuffisance surrénalienne haute symptomatique compliquant l’usage de dermocorticoïdes pour dépigmentation volontaire. La Revue de Médecine Interne. 2008;29(12):1030–3.
14 Sagoe D, Pallesen S, Dlova NC, Lartey M, Ezzedine K, Dadzie O. The global prevalence and correlates of skin bleaching: a meta-analysis and meta-regression analysis. Int J Dermatol. 2019;58(1):24–44.
15 Soo YO-Y, Chow K-M, Lam CW-K, et al. A whitened face woman with nephrotic syndrome. American Journal of Kidney Diseases. 2003;41(1):250–3.